Information to the Marketing Authorisation Holder – Hydroxyzine hydrochloride/Atarax - 13.4.2015

Referral Art. 31, EMEA/H/A-31/1400 regarding Hydroxyzine hydrochloride/Atarax is finished


Receipt of clinical trial applications (CTA) summer 2015 - 27.2.2015

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications from 15 June to 15 August 2015.

The Icelandic Medicines Agency (IMA) introduces electronic signatures - 20.2.2015

An electronic signature leads to more effective resolution of errands, less use of paper and postal cost.

See all